Latest Conference Coverage


Revolutionizing Alzheimer Disease Diagnosis with Blood Biomarkers: Nicholas Ashton, PhD

Revolutionizing Alzheimer Disease Diagnosis with Blood Biomarkers: Nicholas Ashton, PhD

July 20th 2023

The associate professor of neurochemistry at the University of Gothenburg in Sweden talked about a pilot study that explored the potential of finger prick tests to remotely collect blood and provide reliable biomarker results for Alzheimer disease diagnosis. [WATCH TIME: 5 minutes]


Overcoming Complexities With Cognitive Screening in Primary Care Centers: Nicole Fowler, PhD

Overcoming Complexities With Cognitive Screening in Primary Care Centers: Nicole Fowler, PhD

July 20th 2023

The director of research for internal medicine and geriatrics at Indiana University School of Medicine provided perspective on ways to effectively streamline cognitive screening in timely and accurate manor. [WATCH TIME: 4 minutes]


Mortality Risk Significantly Increased With New Opioid Use in Older Adults With Dementia

Mortality Risk Significantly Increased With New Opioid Use in Older Adults With Dementia

July 19th 2023

In total, 33% of the study participants died within 180 days after initiating their first opioid prescription, compared with 6.4% of those unexposed.


Insights on Uncovering the Gut-Brain Interaction and Cognitive Function in Alzheimer Disease

Insights on Uncovering the Gut-Brain Interaction and Cognitive Function in Alzheimer Disease

July 19th 2023

Chaoran Ma, MD, PhD, assistant professor at University of Massachusetts Amherst, talked about the association between bowel movement frequency, the gut microbiome, and cognitive function in patients living with dementia.


Opioid Use and Mortality Risk in Older Patients with Dementia: Christina Jensen-Dahm, MD, PhD

Opioid Use and Mortality Risk in Older Patients with Dementia: Christina Jensen-Dahm, MD, PhD

July 19th 2023

The neurologist in the Danish Dementia Research Center at Rigshospitalet in Copenhagen, Denmark, discussed a cohort study that examined the association between opioid use and the risk of mortality in an older patient population living with dementia. [WATCH TIME: 5 minutes]


Potential Benefit of Nicotinamide Observed in Proof-Of-Concept Trial of Alzheimer Disease

Potential Benefit of Nicotinamide Observed in Proof-Of-Concept Trial of Alzheimer Disease

July 18th 2023

Change in phosphorylated tau231, the primary outcome, favored nicotinamide despite not reaching statistical significance.


Alzheimer Disease Pipeline Update: Inside Look at Promising Agents

Alzheimer Disease Pipeline Update: Inside Look at Promising Agents

July 18th 2023

With the recent approval of lecanemab (Leqembi; Eisai), NeurologyLive took a closer look at the Alzheimer pipeline, and the potential agents clinicians should keep an eye on in the coming years.


Revised Mediterranean Diet Shows No Significant Impact on Cognition, MRI Outcomes in Older Persons

Revised Mediterranean Diet Shows No Significant Impact on Cognition, MRI Outcomes in Older Persons

July 18th 2023

Using a cohort of more than 600 cognitively normal adults, the MIND diet failed to outperform a control diet of mild caloric restriction on several outcomes, including cognition and hippocampal volumes.


Implications of Rising Alzheimer Disease Prevalence Across US Counties: Kumar B. Rajan, PhD

Implications of Rising Alzheimer Disease Prevalence Across US Counties: Kumar B. Rajan, PhD

July 18th 2023

The professor in the department of internal medicine at RUSH Medical College talked about estimating the prevalence of Alzheimer disease to uncover the variability in disease prevalence at a micro-level and its implications for public health programs. [WATCH TIME: 5 minutes]


NeuroVoices: Dustin Hammers, PhD, on Comparative Performance of Cognitive Screening Techniques

NeuroVoices: Dustin Hammers, PhD, on Comparative Performance of Cognitive Screening Techniques

July 18th 2023

The associate professor of neurology at the Indiana University School of Medicine provided commentary on a study comparing traditional cognitive screening methods and the Linus Health Digital Clock and Recall test.


Pimavanserin Safe in Elderly Patients With Neurodegenerative Disease-Related Neuropsychiatric Symptoms

Pimavanserin Safe in Elderly Patients With Neurodegenerative Disease-Related Neuropsychiatric Symptoms

July 17th 2023

In a cohort of nearly 800 frail adults and elderly patients with neuropsychiatric symptoms, pimavanserin showed similar rates of treatment-related adverse events and discontinuations because of TEAEs to placebo.


Donanemab Demonstrates Slowing of Alzheimer Disease Progression in Phase 3 TRAILBLAZER-ALZ 2 Trial

Donanemab Demonstrates Slowing of Alzheimer Disease Progression in Phase 3 TRAILBLAZER-ALZ 2 Trial

July 17th 2023

The clinical relevance of donanemab was demonstrated through a slowing of clinical decline, stability of clinical symptoms, lowered risk of advancement to next clinical stage, and lower risk of meaningful within-patient change.


Differences in Available Cognitive Screening Tools: Dustin Hammers, PhD

Differences in Available Cognitive Screening Tools: Dustin Hammers, PhD

July 17th 2023

The associate professor of neurology at the Indiana University School of Medicine provided insight on the distinguishable characteristics of certain cognitive screening tools and the advantages to each. [WATCH TIME: 3 minutes]


Preparing Primary Care Centers for New Wave of Alzheimer Agents: Nicole Fowler, PhD, MHSA

Preparing Primary Care Centers for New Wave of Alzheimer Agents: Nicole Fowler, PhD, MHSA

July 17th 2023

The director of research for internal medicine and geriatrics at Indiana University School of Medicine provided perspective on navigating challenges with newly approved treatments for Alzheimer disease, and using resources efficiently. [WATCH TIME: 5 minutes]


DCR Test Comparable to Other Traditional Cognitive Screening Assessments, With Less Administration Time

DCR Test Comparable to Other Traditional Cognitive Screening Assessments, With Less Administration Time

July 16th 2023

A comparison between impaired scores on Digital Clock and Recall and impaired scores on Montreal Cognitive Assessment produced a 76% concordance.


Caregivers Perceived Reciprocity Reduces Behavioral Symptoms in Patients With Alzheimer Disease

Caregivers Perceived Reciprocity Reduces Behavioral Symptoms in Patients With Alzheimer Disease

July 16th 2023

According to diary data, caregiver's perceived reciprocity showed a substantial direct influence on the occurrence of behavioral symptoms on both the current day and the subsequent day for patients with Alzheimer disease and related dementias.


Preclinical Research on CRISPR-Based Gene Editing for Alzheimer Disease Treatment: Brent D. Aulston, PhD

Preclinical Research on CRISPR-Based Gene Editing for Alzheimer Disease Treatment: Brent D. Aulston, PhD

July 16th 2023

The postdoctoral fellow at the University of California San Diego discussed using CRISPR-based gene editing to alter the amyloid precursor protein gene in mice models with symptoms of Alzheimer disease. [WATCH TIME: 5 minutes]


Patient-Centric, Knowledge-Driven: Advanced Therapeutics in Movement and Related Disorders™ Congress

Patient-Centric, Knowledge-Driven: Advanced Therapeutics in Movement and Related Disorders™ Congress

July 14th 2023

Clinicians must be armed with fact-based information on all treatment options especially newer medications and technologies—good clinical care must be both patient-centric and knowledge-driven.


Effect of Social Determinants of Health on Brain Aging in Minoritized Patients with Multiple Sclerosis: Cristina A.F. Román, PhD

Effect of Social Determinants of Health on Brain Aging in Minoritized Patients with Multiple Sclerosis: Cristina A.F. Román, PhD

July 13th 2023

The National Multiple Sclerosis Society sponsored research fellow at Kessler Foundation talked about a research project that investigates the differences in brain structure and aging metrics among patients with multiple sclerosis from differing racial and ethnic backgrounds. [WATCH TIME: 5 minutes]


Identifying Effective Big Data Techniques to Address Heterogeneity in Migraine: Ali Ezzati, MD

Identifying Effective Big Data Techniques to Address Heterogeneity in Migraine: Ali Ezzati, MD

July 13th 2023

The director of the Neuroinformatics Program at the University of California, Irvine, discussed complexities with different machine learning algorithms in migraine research, including findings from the AMPP study. [WATCH TIME: 5 minutes]


Generalized Myasthenia Gravis Symptom Severity Reduced Through Ravulizumab Treatment

Generalized Myasthenia Gravis Symptom Severity Reduced Through Ravulizumab Treatment

July 13th 2023

The highest proportions of patients with severe ocular impairment at baseline showed greater improvements in symptom severity on ravulizumab in comparison with placebo after 26 weeks.


Zilucoplan Demonstrates Consistent Efficacy in Phase 3 RAISE Study of  Generalized Myasthenia Gravis

Zilucoplan Demonstrates Consistent Efficacy in Phase 3 RAISE Study of Generalized Myasthenia Gravis

July 12th 2023

Nearly half of patients treated with zilucoplan were considered responders on Myasthenia Gravis Activities of Daily Living (MG-ADL) at the first week, suggesting a rapid onset of efficacy.


Examining Depression and Suicidality in Pediatric Patients With MS: Sarah C. Stoney, MSW, LSW

Examining Depression and Suicidality in Pediatric Patients With MS: Sarah C. Stoney, MSW, LSW

July 12th 2023

The social worker in the Pediatric Multiple Sclerosis Clinic at Children's Hospital of Philadelphia talked about depression and suicidality rates in pediatric patients with multiple sclerosis. [WATCH TIME: 5 minutes]


Efforts Needed to Reach Underserved Communities, Advance Pain Medicine Research: Burel Goodin, PhD

Efforts Needed to Reach Underserved Communities, Advance Pain Medicine Research: Burel Goodin, PhD

July 12th 2023

The professor of anesthesiology at Washington University in St. Louis discussed the reasons behind his presentation at the 2023 AHS Annual Meeting on engaging underserved populations in pain medicine research. [WATCH TIME: 3 minutes]


Enhancing Caregiver and Patient Wellbeing Through a Physical Activity Intervention: Afolasade Fakolade, PhD

Enhancing Caregiver and Patient Wellbeing Through a Physical Activity Intervention: Afolasade Fakolade, PhD

July 11th 2023

The assistant professor at Queen’s University discussed results from a pilot trial that evaluated the impact of a dyadic physical activity intervention among both caregivers and patients with multiple sclerosis. [WATCH TIME: 5 minutes]


Ketogenic Agent Tricaprilin Shows Potential Benefit in Pilot Study of Migraine

Ketogenic Agent Tricaprilin Shows Potential Benefit in Pilot Study of Migraine

July 11th 2023

At month 2 of a 3-month treatment period, investigators observed an improvement of 2.75 days favoring tricaprilin.


Subanalysis of ADAPT Reveals Consistent Efficacy With Efgartigimod Among All Genders

Subanalysis of ADAPT Reveals Consistent Efficacy With Efgartigimod Among All Genders

July 11th 2023

Patients with generalized myasthenia gravis treated with efgartigimod consistently exceeded treatment compared with placebo regardless of gender in age, disease duration, BMI, and thymectomy.


Dedicated Efforts for Improving Sleep Quality in Pediatrics, Adolescents: Sarah Honaker, PhD; Maureen McQuillan, PhD

Dedicated Efforts for Improving Sleep Quality in Pediatrics, Adolescents: Sarah Honaker, PhD; Maureen McQuillan, PhD

July 11th 2023

The duo from Indiana University School of Medicine discussed the ongoing research initiatives to better understand sleep disorders among pediatrics, and ways to improve approaches like cognitive behavioral therapy. [WATCH TIME: 4 minutes]


Exploring the Impact of Indole-3-Lactate in the Gut-Brain Axis and Multiple Sclerosis: Larissa Jank, MD

Exploring the Impact of Indole-3-Lactate in the Gut-Brain Axis and Multiple Sclerosis: Larissa Jank, MD

July 10th 2023

The postdoctoral researcher in the department of neurology at John Hopkins School of Medicine talked about indole-3-lactate as a signaling molecule in the gut-brain axis and its potential as a treatment for MS. [WATCH TIME: 5 minutes]


Finding More Creative and Effective Ways to Teach Neurology: Alexandria Reynolds, PhD

Finding More Creative and Effective Ways to Teach Neurology: Alexandria Reynolds, PhD

July 10th 2023

The undergraduate program director at the University of South Carolina discussed outdated teaching methods used in neurology, and the need to provide different hands-on approaches to students. [WATCH TIME: 5 minutes]

© 2025 MJH Life Sciences

All rights reserved.